E-LIB Suche - Ergebnisse für: Apirat Chaikuad

1

Structure-Guided Design of a Highly Potent Partial RXR Agon..:

Lewandowski, Max ; Carmina, Melania ; Knümann, Loris...
Journal of Medicinal Chemistry. 67 (2024) 3 - p. 2152-2164 , 2024

Link: https://doi.org/10.1021/..

2

Discovery of Potent and Exquisitely Selective Inhibitors of..:

Němec, Václav ; Khirsariya, Prashant ; Janovská, Pavlína...
Angewandte Chemie International Edition. 62 (2023) 11 - p. , 2023

Link: https://doi.org/10.1002/..

3

Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts..:

Bashore, Frances M. ; Marquez, Ariana B. ; Chaikuad, Apirat...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

DARPins detect the formation of hetero-tetramers of p63 and..:

Strubel, Alexander ; Münick, Philipp ; Hartmann, Oliver...
Cell Death & Disease. 14 (2023) 10 - p. , 2023

Link: https://doi.org/10.1038/..

5

Discovery of Potent and Exquisitely Selective Inhibitors of..:

Němec, Václav ; Khirsariya, Prashant ; Janovská, Pavlína...
Angewandte Chemie. 135 (2023) 11 - p. , 2023

Link: https://doi.org/10.1002/..

6

Mutation in the Common Docking Domain Affects MAP Kinase ER..:

Novak, Leonore ; Petrosino, Maria ; Pasquo, Alessandra...
Cancers. 15 (2023) 11 - p. 2938 , 2023

Link: https://doi.org/10.3390/..

7

Targeting the Alternative Vitamin E Metabolite Binding Site..:

Arifi, Silvia ; Marschner, Julian A. ; Pollinger, Julius...
Journal of the American Chemical Society. 145 (2023) 27 - p. 14802-14810 , 2023

Link: https://doi.org/10.1021/..

8

Structure-Based Development of Isoform-Selective Inhibitors..:

Choi, Jun Yong ; Noguchi, Yoshihiko ; Alburger, James M....
Journal of Medicinal Chemistry. 66 (2023) 11 - p. 7162-7178 , 2023

Link: https://doi.org/10.1021/..

9

Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glyc..:

Hasyeoui, Mohamed ; Lassagne, Frédéric ; Erb, William...
Bioorganic Chemistry. 134 (2023) - p. 106456 , 2023

Link: https://doi.org/10.1016/..

10

Design, synthesis and characterisation of a novel type II B..:

Arora, Rohit ; Linders, Joannes T.M. ; Aci-Sèche, Samia...
European Journal of Medicinal Chemistry. 250 (2023) - p. 115231 , 2023

Link: https://doi.org/10.1016/..

11

Target 2035 – update on the quest for a probe for every pro..:

Müller, Susanne ; Ackloo, Suzanne ; Al Chawaf, Arij...
RSC Medicinal Chemistry. 13 (2022) 1 - p. 13-21 , 2022

Link: https://doi.org/10.1039/..

12

Designed Ankyrin Repeat Proteins as a tool box for analyzin..:

Strubel, Alexander ; Münick, Philipp ; Chaikuad, Apirat...
Cell Death & Differentiation. 29 (2022) 12 - p. 2445-2458 , 2022

Link: https://doi.org/10.1038/..

13

Rational Design of a New RXR Agonist Scaffold Enabling Sing..:

Adouvi, Gustave ; Isigkeit, Laura ; López-García, Úrsula...
Journal of Medicinal Chemistry. 66 (2022) 1 - p. 333-344 , 2022

Link: https://doi.org/10.1021/..

14

Design of a Potent TLX Agonist by Rational Fragment Fusion:

Faudone, Giuseppe ; Zhubi, Rezart ; Celik, Fatih...
Journal of Medicinal Chemistry. 65 (2022) 3 - p. 2288-2296 , 2022

Link: https://doi.org/10.1021/..

15

Kinase Domain Autophosphorylation Rewires the Activity and ..:

Cullati, Sierra ; Chaikuad, Apirat ; Chen, Jun‐Song...
The FASEB Journal. 36 (2022) S1 - p. , 2022

Link: https://doi.org/10.1096/..